https://clicap.org/publicacion/revista-factor-rh/2024-01-18T10:37:33-06:00https://clicap.org/publicacion/salud-news/2024-01-18T10:37:28-06:00https://clicap.org/publicacion/publicacion-de-tipo-estudio-nuevo/2024-02-06T08:55:10-06:00https://clicap.org/publicacion/genotyping-non-small-cell-lung-cancer-nsclc-in-latin-america/2024-02-05T11:07:55-06:00https://clicap.org/publicacion/the-impact-of-common-and-rare-egfr-mutations-in-response-to-egfrtyrosine-kinase-inhibitors-and-platinum-based-chemotherapy-inpatients-with-non-small-cell-lung-cancer/2024-02-05T11:07:52-06:00https://clicap.org/publicacion/updated-frequency-of-egfr-and-kras-mutations-in-nonsmall-cell-lung-cancer-in-latin-america-the-latin-american-consortium-for-the-investigation-of-lung-cancer-clicap/2024-02-05T11:07:47-06:00https://clicap.org/publicacion/predictive-value-of-pre-treatment-inflammatory-markers-in-advanced-non-small-cell-lung-cancer-nsclc-clicap/2024-02-05T11:07:20-06:00https://clicap.org/publicacion/pemetrexed-carboplatin-bevacizumab-followed-by-maintenance-pemetrexed-bevacizumab-in-hispanic-patients-with-non-squamous-non-small-cell-lung-cancer-outcomes-according-to-thymidylate-synthase-expressi/2024-02-05T11:08:36-06:00https://clicap.org/publicacion/acquired-resistance-to-erlotinib-in-egfr-mutation-positive-lung-adenocarcinoma-among-hispanics-clicap/2024-02-05T11:09:10-06:00https://clicap.org/publicacion/an-international-epidemiological-analysis-of-young-patients-with-non-small-cell-lung-cancer-adujov-clicap/2024-02-05T11:09:42-06:00https://clicap.org/publicacion/survival-outcomes-according-to-timp1-and-egfr-expression-in-heavily-treated-patients-with-advanced-non-small-cell-lung-cancer-who-received-biweekly-irinotecan-plus-bevacizumab/2024-02-05T11:10:10-06:00https://clicap.org/publicacion/characteristics-of-progression-to-tyrosine-kinase-inhibitors-predict-overall-survival-in-patients-with-advanced-non-small-cell-lung-cancer-harboring-an-egfr-mutation/2024-02-05T11:10:37-06:00https://clicap.org/publicacion/egfr-exon-20-insertion-in-lung-adenocarcinomas-among-hispanics-geno1-2-clicap/2024-02-05T11:11:48-06:00https://clicap.org/publicacion/molecular-epidemiology-of-alk-rearrangements-in-advanced-lung-adenocarcinoma-in-latin-america/2024-02-05T11:12:17-06:00https://clicap.org/publicacion/characteristics-and-long-term-outcomes-of-advanced-pleural-mesothelioma-in-latin-america-meso-clicap/2024-02-05T11:12:42-06:00https://clicap.org/publicacion/multigene-mutation-profiling-and-clinical-characteristics-of-small-cell-lung-cancer-in-never-smokers-vs-heavy-smokers-geno1-3-clicap/2024-02-05T11:13:59-06:00https://clicap.org/publicacion/immunotherapy-at-any-line-of-treatment-improves-survival-in-patients-with-advanced-metastatic-non-small-cell-lung-cancer-nsclc-compared-with-chemotherapy-quijote-clicap/2024-02-05T11:14:25-06:00https://clicap.org/publicacion/genotyping-squamous-cell-lung-carcinoma-in-colombia-geno1-1-clicap/2024-02-05T11:15:00-06:00https://clicap.org/publicacion/scientific-publications-in-cancer-in-latin-america-strong-scientific-networks-increase-productivity-the-tenjin-study/2024-02-05T11:15:28-06:00https://clicap.org/publicacion/mentoring-as-an-opportunity-to-improve-research-and-cancer-care-in-latin-america-aazpire-project/2024-02-05T11:17:00-06:00https://clicap.org/publicacion/new-opportunities-in-a-challenging-disease-lurbinectedin-for-relapsed-small-cell-lung-cancer/2024-02-05T11:17:37-06:00https://clicap.org/publicacion/recommendations-for-detection-prioritization-and-treatment-of-thoracic-oncology-patients-during-the-covid-19-pandemic-the-thocoop-cooperative-group/2024-02-05T11:18:10-06:00https://clicap.org/publicacion/brigatinib-in-alk-positive-non-small-cell-lung-cancer-real-world-data-in-the-latin-american-population-bri-world-extend-clicap/2024-02-05T11:19:04-06:00https://clicap.org/publicacion/lung-cancer-in-never-smokers-the-role-of-different-risk-factors-other-than-tobacco-smoking/2024-02-05T11:19:29-06:00https://clicap.org/publicacion/antibiotics-impair-immune-checkpoint-inhibitor-effectiveness-in-hispanic-patients-with-non-small-cell-lung-cancer-ab-clicap/2024-02-05T11:20:01-06:00https://clicap.org/publicacion/mortality-and-advanced-support-requirement-for-patients-with-cancer-with-covid-19-a-mathematical-dynamic-model-for-latin-america/2024-02-05T11:20:30-06:00https://clicap.org/publicacion/egfr-inhibitors-plus-bevacizumab-are-superior-than-egfr-inhibitors-alone-as-first-line-setting-in-advanced-nsclc-with-egfr-mutations-and-bim-deletion-polymorphisms-bim-clicap/2024-02-05T11:22:18-06:00https://clicap.org/publicacion/characteristics-and-outcomes-of-thymomas-in-latin-americaresults-from-over-10-years-of-experience-clicap-latimus/2024-02-05T11:48:14-06:00https://clicap.org/publicacion/association-of-carcinoembryonic-antigen-reduction-with-progression-free-and-overall-survival-improvement-in-advanced-non-small-cell-lung-cancer/2024-02-05T11:48:48-06:00https://clicap.org/publicacion/egfr-amplification-and-sensitizing-mutations-correlate-with-survival-in-lung-adenocarcinoma-patients-treated-with-erlotinib-mutp-clicap/2024-02-05T11:49:37-06:00https://clicap.org/publicacion/mechanisms-of-resistance-to-first-line-osimertinib-in-hispanic-patients-with-egfr-mutant-non-small-cell-lung-cancer-freston-clicap/2024-02-05T11:50:29-06:00https://clicap.org/publicacion/mentoring-as-an-opportunity-to-improve-research-and-cancer-care-in-latin-america-aazpire-project-2/2024-02-05T11:51:02-06:00https://clicap.org/publicacion/durvalumab-after-chemoradiation-for-unresectable-stage-iii-non-small-cell-lung-cancer-inferior-outcomes-and-lack-of-health-equity-in-hispanic-patients-treated-with-pacific-protocol-la1-clicap/2024-02-05T11:51:48-06:00https://clicap.org/publicacion/stk11-and-keap1-mutations-in-non-small-cell-lung-cancer-patients-descriptive-analysis-and-prognostic-value-among-hispanics-strike-registry-clicap/2024-02-05T11:52:13-06:00https://clicap.org/publicacion/human-papillomavirus-infection-and-lung-adenocarcinoma-special-benefit-is-observed-in-patients-treated-with-immune-checkpoint-inhibitors/2024-02-05T11:52:45-06:00https://clicap.org/publicacion/p-g12c-kras-mutation-prevalence-in-non-small-cell-lung-cancer-contribution-from-interregional-variability-and-population-substructures-among-hispanics/2024-02-05T11:53:13-06:00https://clicap.org/publicacion/characteristics-and-outcomes-of-hispanic-patients-with-ret-fusion-positive-nsclc-treated-in-real-world-practice/2024-02-05T12:06:32-06:00https://clicap.org/publicacion/real-world-study-on-efficacy-of-first-line-nivolumab-ipilimumab-in-unresectable-malignant-pleural-mesothelioma-immunomeso/2024-02-05T12:08:18-06:00https://clicap.org/publicacion/perilesional-edema-diameter-associated-with-brain-metastases-as-a-predictive-factor-of-response-to-radiotherapy-in-non-small-cell-lung-cancer/2024-02-05T12:44:43-06:00https://clicap.org/publicacion/ep12-01-65-prognostic-value-of-sequential-liquid-biopsy-lb-after-osimertinib-among-hispanic-patients-with-advanced-egfr-mutant-nsclc/2024-02-06T08:41:49-06:00https://clicap.org/publicacion/ep12-03-04-prognostic-value-of-tp53-commutations-among-hispanic-patients-with-advanced-egfr-positive-nsclc-treated-with-first-line-osimertinib/2024-02-06T08:42:47-06:00https://clicap.org/publicacion/pd-l1-expression-complements-calgb-prognostic-scoring-system-in-malignant-pleural-mesothelioma/2024-02-06T08:51:53-06:00